[
  {
    "ts": "2025-09-12T14:25:00+00:00",
    "headline": "Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects",
    "summary": "Pfizer's late-stage pipeline, from oncology blockbusters to mRNA vaccines, positions it for long-term growth despite recent setbacks.",
    "url": "https://finance.yahoo.com/news/pfizers-stage-pipeline-fuels-long-142500413.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b2963eb4-ca1a-3cb0-b9b5-428ddf7f0cac",
      "content": {
        "id": "b2963eb4-ca1a-3cb0-b9b5-428ddf7f0cac",
        "contentType": "STORY",
        "title": "Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects",
        "description": "",
        "summary": "Pfizer's late-stage pipeline, from oncology blockbusters to mRNA vaccines, positions it for long-term growth despite recent setbacks.",
        "pubDate": "2025-09-12T14:25:00Z",
        "displayTime": "2025-09-12T14:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.Z6CaNjdpI8OLeo5.Ul_eA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o6kyOwY40meLORq99yf8XA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizers-stage-pipeline-fuels-long-142500413.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizers-stage-pipeline-fuels-long-142500413.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "1530.HK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T13:08:00+00:00",
    "headline": "BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?",
    "summary": "Bristol Myers and BioNTech report strong mid-stage lung cancer trial data for pumitamig, showing high response rates and manageable safety.",
    "url": "https://finance.yahoo.com/news/bmy-biontech-partnership-potential-catalyst-130800410.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "98ce2212-ac8c-3f75-804a-9f2c4009ce85",
      "content": {
        "id": "98ce2212-ac8c-3f75-804a-9f2c4009ce85",
        "contentType": "STORY",
        "title": "BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?",
        "description": "",
        "summary": "Bristol Myers and BioNTech report strong mid-stage lung cancer trial data for pumitamig, showing high response rates and manageable safety.",
        "pubDate": "2025-09-12T13:08:00Z",
        "displayTime": "2025-09-12T13:08:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmy-biontech-partnership-potential-catalyst-130800410.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmy-biontech-partnership-potential-catalyst-130800410.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BNTX"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T07:00:00+00:00",
    "headline": "Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl",
    "summary": "For U.S. Big Pharma companies, vaccines have largely been an afterthought. But by 2030, they could be a quarter of Pfizer’s revenue.",
    "url": "https://www.barrons.com/articles/vaccines-kennedy-drugs-pfizer-stock-price-d6ad6c92?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "59f47854-18f2-3846-b389-4389b84a23c8",
      "content": {
        "id": "59f47854-18f2-3846-b389-4389b84a23c8",
        "contentType": "STORY",
        "title": "Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl",
        "description": "",
        "summary": "For U.S. Big Pharma companies, vaccines have largely been an afterthought. But by 2030, they could be a quarter of Pfizer’s revenue.",
        "pubDate": "2025-09-12T07:00:00Z",
        "displayTime": "2025-09-12T07:00:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/59f47854-18f2-3846-b389-4389b84a23c8/pfizer-is-growing-more.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/d3cfebceea7277daf22dd9f582ecd686",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/skS79MNWgL9rx.cTbE3jlg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/d3cfebceea7277daf22dd9f582ecd686.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GjK4ZOEIH_zDbYzQ.ImuNw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/d3cfebceea7277daf22dd9f582ecd686.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/vaccines-kennedy-drugs-pfizer-stock-price-d6ad6c92?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "SAN.PA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T04:03:06+00:00",
    "headline": "3 Reasons to Sell BMY and 1 Stock to Buy Instead",
    "summary": "What a brutal six months it’s been for Bristol-Myers Squibb. The stock has dropped 20.5% and now trades at $47.55, rattling many shareholders. This may have investors wondering how to approach the situation.",
    "url": "https://finance.yahoo.com/news/3-reasons-sell-bmy-1-040306628.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "00807389-7695-37e0-9206-b84cfb614b87",
      "content": {
        "id": "00807389-7695-37e0-9206-b84cfb614b87",
        "contentType": "STORY",
        "title": "3 Reasons to Sell BMY and 1 Stock to Buy Instead",
        "description": "",
        "summary": "What a brutal six months it’s been for Bristol-Myers Squibb. The stock has dropped 20.5% and now trades at $47.55, rattling many shareholders. This may have investors wondering how to approach the situation.",
        "pubDate": "2025-09-12T04:03:06Z",
        "displayTime": "2025-09-12T04:03:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "BMY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gk.7_kJOBQAPS7VxEfLOgw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YM1F85oh4xO4w1Qalh6PGw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-sell-bmy-1-040306628.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-sell-bmy-1-040306628.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]